Driehaus Capital Management »

Sagimet Biosciences Inc-a shares owned by Driehaus Capital Management

Quarter-by-quarter ownership of Sagimet Biosciences Inc-a (SGMT) shares owned by Driehaus Capital Management from 13F filings

Historical chart of Driehaus Capital Management investment in Sagimet Biosciences Inc-a

Tip: Access up to 7 years of quarterly data

All positions including Sagimet Biosciences Inc-a held by Driehaus Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Sagimet Biosciences Inc-a by Driehaus Capital Management

Quarter filed Position value Share count Share price at filing
2026-06-30 $1.3M 167k 7.73

More positions owned by Driehaus Capital Management

TSMC Adr (TSM)
Definium Therape (DFTX)
Praxis Precision Medicines I (PRAX)
Xenon Pharmaceuticals (XENE)
Silicon Motion Technology Corp Adr (SIMO)
Aeglea Biotherapeutics (SYRE)
Crinetics Pharmaceuticals In (CRNX)
Apogee Therapeutics (APGE)
Guardant Health (GH)
Planet Labs Pbc Com Cl A (PL)
Credicorp (BAP)
Edgewise Therapeutics (EWTX)
Vicor Corporation (VICR)
Ultra Clean Holdings (UCTT)
Curtiss-Wright (CW)

View all positions for Driehaus Capital Management

Top funds holding Sagimet Biosciences Inc-a

BlackRock
Balyasny Asset Management
Woodline Partners
Silverarc Capital Management
Vanguard Capital Management
BVF
Caligan Partners
Affinity Asset Advisors
Federated Investors
Dr. Jeffrey R. Jay, M.D.
Saturn V Capital Management
Geode Capital Management
Blue Owl Capital Holdings
Baker Bros. Advisors
Millennium Management

View all funds holding Sagimet Biosciences Inc-a